Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Supranuclear Palsy (PSP)”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Not applicableStudy completedNCT02966145
What this trial is testing

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

Who this might be right for
Corticobasal Degeneration (CBD)Corticobasal Syndrome (CBS)Cortical-basal Ganglionic Degeneration (CBGD)+3 more
University of California, San Francisco 293
Testing effectiveness (Phase 2)UnknownNCT04253132
What this trial is testing

Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks

Who this might be right for
Progressive Supranuclear Palsy
NeuroTau, Inc. 24
Not applicableLooking for participantsNCT04706234
What this trial is testing

Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

Who this might be right for
Multiple System AtrophyParkinson DiseaseProgressive Supranuclear Palsy+2 more
Kliniken Beelitz GmbH 350
Not applicableLooking for participantsNCT04468932
What this trial is testing

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

Who this might be right for
Palsy SupranuclearSupranuclear Palsy, Progressive
Oregon Health and Science University 30
Not applicableStudy completedNCT04655079
What this trial is testing

Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Progressive Supranuclear Palsy (PSP) (STIM-PSP)

Who this might be right for
Progressive Supranuclear PalsyMotor and Cognitive Symptoms
University of Salerno 24
Not applicableLooking for participantsNCT06645626
What this trial is testing

Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes

Who this might be right for
Progressive Supranuclear PalsyCortico Basal DegenerationMultiple System Atrophy
University Hospital Southampton NHS Foundation Trust 198
Testing effectiveness (Phase 2)Ended earlyNCT03391765
What this trial is testing

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

Who this might be right for
Progressive Supranuclear Palsy (PSP)
AbbVie 142
Not applicableStudy completedNCT00382824
What this trial is testing

Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)

Who this might be right for
Progressive Supranuclear Palsy
Lahey Clinic 61
Early research (Phase 1)Study completedNCT04539041
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy (PSP)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT04193527
What this trial is testing

Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Who this might be right for
Parkinsonian SyndromeParkinson Disease(PD)Multiple System Atrophy (MSA)+2 more
GE Healthcare 172
Large-scale testing (Phase 3)Study completedNCT02839642
What this trial is testing

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy (PSP)
Assistance Publique Hopitaux De Marseille 106
Not applicableStudy completedNCT03452956
What this trial is testing

Cognitive Impairement In Frontotemporal Dementia

Who this might be right for
Frontotemporal DegenerationProgressive Supranuclear PalsyMultiple System Atrophy
University of Pennsylvania 997
Early research (Phase 1)Study completedNCT02103894
What this trial is testing

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Who this might be right for
Alzheimer's Disease (AD)Parkinson's Disease (PD)Chronic Traumatic Encephalopathy (CTE)+4 more
Molecular NeuroImaging 16
Not applicableStudy completedNCT01174771
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration

Who this might be right for
Progressive Supranuclear PalsyCorticobasal DegenerationParkinsonism
University of California, Los Angeles 30
Early research (Phase 1)Study completedNCT02494024
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
C2N Diagnostics 32
Testing effectiveness (Phase 2)Looking for participantsNCT06162013
What this trial is testing

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Who this might be right for
Progressive Supranuclear PalsyMultiple System AtrophyCorticobasal Syndrome
Haukeland University Hospital 330
Not applicableLooking for participantsNCT03638505
What this trial is testing

Quality of Life of the Patient and the Burden of the Caregiver in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
Assistance Publique Hopitaux De Marseille 200
Very early researchStudy completedNCT02531360
What this trial is testing

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Who this might be right for
Alzheimer's Disease (AD)Progressive Supranuclear Palsy (PSP)Cortical Basal Syndrome (CBS)+1 more
Molecular NeuroImaging 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07264283
What this trial is testing

The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31

Who this might be right for
PSP - Progressive Supranuclear Palsy
Adam Boxer 147
Not applicableUnknownNCT03330353
What this trial is testing

Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy

Who this might be right for
PSP - Progressive Supranuclear PalsyPD - Parkinson's DiseaseAD - Alzheimer's Disease+1 more
Massachusetts General Hospital 56
Load More Results